Harley’s lymphoma tumour shock
Harley and his family stayed in Leukaemia Foundation accommodation during his Burkitt's lymphoma treatment.
- Non-Hodgkin lymphoma
- Support services
Harley and his family stayed in Leukaemia Foundation accommodation during his Burkitt's lymphoma treatment.
A world-first research group is investigating a new therapeutic approach.
In a world first, the Australian COMMITTAL trial uses CAR T-cell therapy to improve survival for people with B-cell ALL who have an allogeneic stem cell transplant.
The Leukaemia Foundation welcomes Federal Labor’s commitment of $20 million to give Australian blood cancer patients faster access to leading clinical trial drugs and therapies through a new Right to Trial program.
Seven-year-old Chloe stayed at our Stirling Cross Village in Perth while undergoing treatment for acute myeloid leukaemia.
Thanks to Holden’s generous support, more than 4500 Australian families are able to get to and from hospital for vital treatment each year – free of charge.
There’s now an innovative way for people living with chronic myeloid leukaemia to support vitally needed medical research.
Kimberly Stegmaier's research focuses on finding new therapeutic targets for children with cancer.
Richard was affected by skin GVHD after his transplant for AML.
Researchers have discovered why half of patients with a type of high-risk blood cancer will not respond to a common treatment.